Late Oncology Strategy & Program Lead

Jazz Pharmaceutical; United States; Vor Ort; USD 230.000 - 346.000; Vollzeit

Benefits dieser Stelle

Medical, dental and vision insurance

401k retirement savings plan

Flexible paid vacation

Zusammenfassung

Jazz Pharmaceuticals is seeking a Senior Director, Head of Late Oncology Program Management to lead strategic and operational efforts for late-stage oncology and early-phase programs. The role partners with Clinical Development leadership to shape study design, feasibility, and execution while safeguarding budgets and timelines.

The position emphasizes global collaboration, governance oversight, and talent development across a matrix organization to deliver pivotal oncology trials on time and

Qualifikationen

• Late Oncology track record delivering complex trials.
• Experience partnering with Clinical Development Leads.
• Strong governance & budgeting capabilities.

Aufgaben

• Define strategic vision for Late Oncology / Early Phase PMO.
• Lead and develop the Clinical Operations Leadership Team.
• Ensure end-to-end execution of late-phase oncology trials within scope and budget.
• Partner with CROs, academia, and KOLs to support study delivery.
• Oversee global budgets, timelines, and resource planning for governance committees.
• Mentor and grow a high-performing team of directors and associate directors.

Kenntnisse

Strategic leadership

Budgeting & governance

Clinical operations

Global study management

Cross-functional partnering

Program management

Vendor management

Decision making

Ausbildung

PhD/PharmD/MS preferred

Bachelor's degree with experience

Jobbeschreibung

Jazz Pharmaceuticals is seeking a Senior Director, Head of Late Oncology Program Management to lead strategic and operational efforts for late-stage oncology and early-phase programs. The role partners with Clinical Development leadership to shape study design, feasibility, and execution while safeguarding budgets and timelines.

The position emphasizes global collaboration, governance oversight, and talent development across a matrix organization to deliver pivotal oncology trials on time and